[Clinical practice guideline for quality control of hemodiafiltration]

    Zhonghua Yi Xue Za Zhi
    |February 23, 2024
    PubMed

    Insights

    This guideline provides expert recommendations for hemodiafiltration (HDF) in China, covering indications, treatment, and complication management to standardize medical quality.

    Area of Science:

    • Nephrology
    • Renal Replacement Therapy

    Context:

    • Hemodiafiltration (HDF) is a crucial renal replacement therapy.
    • Clinical practice guidelines and expert recommendations form the basis of this guideline.
    • The Standard Operating Procedures for Blood Purification (2021 Edition) were also referenced.

    Purpose:

    • To guide clinical practice and research in hemodiafiltration within China.
    • To enhance the standardization, normalization, and homogeneity of medical quality in HDF.
    • To address key clinical and quality control issues in HDF.

    Summary:

    • Covers indications for hemodiafiltration, treatment mode selection, and replacement fluid adjustments.
    • Addresses vascular access, anticoagulation therapy, prescription setting, and complication prevention/treatment.
    • Based on evidence-based resources, current guidelines, and expert recommendations.

    Impact:

    • Aims to improve the quality of hemodiafiltration care in China.
    • Promotes standardized and normalized medical practices.
    • Facilitates advancements in clinical research for hemodiafiltration.